(Q37060085)

18 August 2017

Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation (English)

1 reference

18 August 2017

0 references

0 references

Masahito Jimbo

1

1 reference

18 August 2017

Ronald E Myers

2

1 reference

18 August 2017

Birgit Meyer

3

1 reference

18 August 2017

Terry Hyslop

4

1 reference

18 August 2017

James Cocroft

5

1 reference

18 August 2017

Barbara J Turner

6

1 reference

18 August 2017

David S Weinberg

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

Annals of Family Medicine

18 August 2017

1 reference

18 August 2017

7

1 reference

18 August 2017

1

1 reference

18 August 2017

11-16

1 reference

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Colorectal cancer screening, comorbidity, and follow-up in elderly patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Screening for colorectal cancer: recommendation and rationale

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Randomised study of screening for colorectal cancer with faecal-occult-blood test

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Barriers to full colon evaluation for a positive fecal occult blood test

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Measuring the quality of colorectal cancer screening: the importance of follow-up.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2625842

Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey

4 September 2018

1 reference

12 December 2020

Measuring complete diagnostic evaluation in colorectal cancer screening

1 reference

12 December 2020

Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings

1 reference

12 December 2020

Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests

1 reference

12 December 2020

Impact of a physician-oriented intervention on follow-up in colorectal cancer screening

1 reference

12 December 2020

Optimal dietary conditions for hemoccult testing

1 reference

12 December 2020

A critical analysis of the largest reported mass fecal occult blood screening program in the United States

1 reference

12 December 2020

Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation

1 reference

12 December 2020

1 reference

12 December 2020

Diagnostic testing following fecal occult blood screening in the elderly

1 reference

12 December 2020

A national survey of primary care physicians' methods for screening for fecal occult blood

1 reference

12 December 2020

Increased use of colorectal cancer tests--United States, 2002 and 2004

1 reference

12 December 2020

Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood

1 reference

12 December 2020

Identifiers

DOI

10.1370/AFM.906

1 reference

18 August 2017

1 reference

18 August 2017

1 reference